RE: Unilever explores further opportunities with Aptamer.11 Sep 2024 10:09
Deltalo I would not be surprised to see Astrazeneca make a bid for the company They have a tremendous amount to gain if their testing is proven good and they are extremely acquisitive. They too have free cash by the bucket load. DYOR but there is clearly a lot going on here.